Suggestions
James Hugg, PhD, MBA
President, CTO, and Co-founder at SmartBreast Corporation
James Hugg, PhD, MBA, is an adjunct professor of Physics at LeTourneau University. He holds advanced degrees in both physics and business administration, reflecting a blend of technical expertise and managerial skills. Currently, he is also involved with SmartBreast Corp, where he applies his knowledge in technology and problem-solving to drive innovation in the field of breast imaging technology.1
In addition to his academic role, Hugg has a strong background in technology leadership and decision-making, which enhances his contributions both in educational settings and industry applications. His LinkedIn profile indicates a commitment to advancing medical technologies through his work.1
Highlights
I'm starting a new position as President and CTO, Co-Founder at SmartBreast Corp! I have stepped down from the Founding CEO position to allow a seasoned Marketing and Sales executive to take the reins and drive SmartBreast to commercial success. We will introduce our new CEO soon.
MBI Saves 3 Times as Many Lives as Mammography
If I were a woman with dense breasts, I would demand to be screened by MBI (Molecular Breast Imaging). Our wives do…
The reason is simple: supplemental screening with MBI saves more than 3 times as many lives as digital mammography (DM) and more than 2 times as many lives as 3D-DM (also called DBT, digital breast tomosynthesis). Just see the chart from published clinical studies. [1]
Some marketers make a big deal by claiming that DBT is better than DM. They’re correct, but that’s not the whole story. It just happens to be the best story they can tell…
The whole truth is, MBI is a much better instrument for finding early-stage cancers in dense breasts. And about half of women have dense breasts (up to 70% of Asian women).
You see, DM and DBT both use low-energy X-rays that cannot penetrate dense breast tissue. Over half of early-stage cancers are missed in dense breasts [1] because cancer and dense tissue are both white on mammograms. It’s hard to see a white rabbit in a blizzard.
But MBI has several big advantages:
-
the “molecular imaging” part of the name indicates that MBI uses a tracer molecule that is strongly absorbed by cancer cells;
-
MBI places a special tag on the tracer molecules that emits a beacon of gamma photons (the more energetic cousin of X-rays) that pass safely through dense breast tissue;
-
two special high-tech solid-state gamma cameras that image the gamma photon beacons from cancer cells;
-
unlike the painful breast compression of DM and DBT, MBI gently and painlessly immobilizes the breast during imaging; and
-
MBI is much easier for your breast radiologist to read.
Ask your breast care provider to learn more about MBI. Your life may depend on it.
[1] Brown, M & Covington, MF, Radiology: Imaging Cancer, 2019; 1(1):e190005.
#mbi #densebreast #smartbreast #breastcancer #mammography #dbt James Hugg, PhD, MBA, Bradley Patt, PhD, Martin Tornai, PhD, Eduardo A. Santos, M.D.
